Challenges of Engineering Yeast to Produce Drugs

Christina Smolke is the co-founder and CEO of Antheia. Antheia is a synthetic biology company -- they’re in the business of genetically engineering microorganisms to produce commercial products.

Christina’s problem is this: How do you turn yeast cells into tiny factories to create the active ingredients in generic drugs. If Christina and her team solve this problem, they won’t solve the drug shortage problem entirely. But they might help make it better.

See omnystudio.com/listener for privacy information.